Home » Topics » Conferences

Conferences
RSS

Placebo associated with improvement and side effects in treatment of BPH

April 16, 1997

GG-745 compared to finasteride in BPH patients

April 15, 1997

TGF-beta1 antisense vaccine effective in rat prostate cancer model

April 15, 1997

Furosemide vs. placebo for nocturnal polyuria

April 15, 1997

Nasal midazolam safe and effective for anterograde amnesia in children undergoing VCUG

April 15, 1997

DuPont Merck reports orally active acetylcholine release enhancer

April 15, 1997

New COX-2 inhibitor from Searle

April 15, 1997

Nitrosylated alpha-adrenoceptor antagonists for erectile dysfunction

April 15, 1997

Melanotropic peptide effective in men with erectile dysfunction

April 15, 1997

Initial clinical results with vinpocetine for urge incontinence

April 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
ASH 2025: Ianalumab data offer break from chronic ITP therapy
BioWorld
Novartis AG’s monoclonal antibody, ianalumab (VAY-736), when added to standard-of-care eltrombopag, extended disease control of primary immune thrombocytopenia...